OWP
LEGN icon

Old Well Partners’s Legend Biotech LEGN Stock Holding History

Old Well Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,301
Closed -$1.3M – 24
2024
Q2 		$1.3M Sell
29,301
-12,700
-30% -$586K 1.42% 25
2024
Q1 		$2.36M Hold
42,001
– – 1.98% 22
2023
Q4 		$2.53M Sell
42,001
-3,199
-7% -$203K 2.23% 18
2023
Q3 		$3.04M Buy
+45,200
New +$3.14M 2.52% 18
2022
Q2 		– Sell
-79,700
Closed -$2.9M – 34
2022
Q1 		$2.9M Hold
79,700
– – 1.95% 24
2021
Q4 		$3.71M Buy
+79,700
New +$4.04M 2.3% 21

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Old Well Partners's LEGN Position: Q3 2024 in Review

Old Well Partners sold out of Legend Biotech (LEGN) in Q3 2024, closing a stake of 29,301 shares — an estimated $1.3M sold.

Old Well Partners first reported a position in LEGN in Q4 2021 and held it in 6 quarters. The position peaked at $3.71M in Q4 2021. 207 funds tracked by Wall St. Rank hold LEGN as of Q3 2024.

  • Old Well Partners reported no remaining Legend Biotech position as of Q3 2024 after selling out during the quarter.
  • Old Well Partners sold 29,301 Legend Biotech shares in Q3 2024, an estimated $1.3M.
  • Old Well Partners first reported a position in Legend Biotech in Q4 2021 and held it in 6 quarters.
  • Old Well Partners's Legend Biotech position peaked at $3.71M in Q4 2021.
  • 207 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2024.

Based on Old Well Partners's 13F filing for Q3 2024, filed 14 Nov 2024.